查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1734896

2032 年腦植入市場預測：按產品、應用、最終用戶和地區進行的全球分析

Brain Implants Market Forecasts to 2032 - Global Analysis By Product, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球腦植入市場預計在 2025 年達到 74 億美元，到 2032 年將達到 162.6 億美元，預測期內的複合年成長率為 11.9%。

被稱為腦植入的先進醫療設備直接植入大腦，以促進與神經組織的溝通。這些植入具有廣泛的治療、診斷和增強應用。植入透過電極發送和接收電訊號來捕捉或誘發大腦活動。材料科學、無線技術和機器學習的最新進展大大提高了腦植入的安全性、功能性和潛在應用。

根據美國神經外科醫師協會 (AANS) 的數據，肌張力不全症是一種以不自主肌肉收縮為特徵的神經運動障礙，影響著美國約 25 萬人。

神經系統疾病盛行率不斷上升

在全球範圍內，神經系統疾病的發生率正以驚人的速度成長。全球數百萬人飽受癲癇、帕金森氏症、阿茲海默症、慢性疼痛和憂鬱症等頑固性疾病的折磨。例如，世界衛生組織 (WHO) 估計，全球有超過 5,000 萬人患有癲癇。腦植入透過控制異常神經元活動並提高患者的生活品質，提供了一種有效的干涉措施。此外，由於常規治療常常失敗，尤其是在患者出現抗藥性的情況下，對植入式神經刺激設備的需求也日益成長。

昂貴的手術和設備

深部腦部刺激 (DBS) 系統和其他腦植入價格昂貴，每位患者的費用在 3.5 萬美元至 5 萬美元之間，這還不包括手術和術後費用。高昂的初始成本和持續成本是推廣此類療法的一大障礙，尤其是在中低收入國家。即使在已開發國家，保險覆蓋範圍也可能有限，這阻礙了患者選擇此類治療。此外，這些成本也會對醫療保健系統產生影響，尤其是在考慮長期監測、設備維護以及可能需要調整的潛在問題時。

腦機介面（BCI）的發展

腦機介面 (BCI) 將大腦植入與外部運算系統相整合，為醫療保健和其他領域開闢了革命性的可能性。借助 BCI，截肢者或癱瘓者可以利用神經訊號操作電腦、輪椅或義肢。 Syncron 的血管內 BCI 和馬斯克的 Neuralink 等計畫正在吸引人們的關注，並吸引資金用於治療和非醫療用途。此外，隨著這些技術的發展及其在通訊、遊戲、智慧設備和增強認知等領域的商業化部署，腦植入市場可能會顯著擴展到傳統醫療領域之外。

道德抵制和公眾懷疑

儘管技術潛力巨大，但由於倫理和哲學方面的問題，大眾仍然對腦植入持懷疑態度。倡導團體和病人可能難以接受一個人被精神控制、失去自主權並經歷人格改變。在那些因宗教或文化原因而高度重視人腦神聖性的社會中，侵入性手術往往會遭到抵制。此外，隨著腦植入開始混淆增強功能和治療功能，關於倫理界線和潛在濫用的爭論日益增多，導致一些市場對其實施限制或禁令。

COVID-19的影響：

新冠疫情對腦植入市場造成了多方面的影響。初期市場波動包括：由於供應鏈中斷、醫院容量減少、擇期神經外科手術延後，植入手術和臨床試驗數量暫時下降。然而，隨著醫療系統轉向尖端的遠端病患監控和慢性病管理解決方案，疫情也加速了對神經技術和數位醫療的投資。此外，腦霧、中風和認知障礙等長期新冠相關神經系統併發症的盛行率上升，預計也將推動市場長期成長。

深層腦部刺激器(DBS) 市場預計將成為預測期內最大的市場

預計深層腦部刺激器(DBS) 領域將在預測期內佔據最大的市場佔有率。 DBS 是最廣泛使用的神經調節療法，因為它在臨床上取得了成功，並廣泛應用於治療帕金森氏症、自發性震顫、肌張力不全症和強迫性精神官能症。該治療方法透過在特定腦區植入電極並傳遞受控電脈衝，有效地調節異常神經活動。此外，它已獲得 FDA已通過核准，技術成熟，並有大量臨床數據支持。此外，設備小型化、電池壽命和 MRI 相容性的技術創新正在推動其普及。

預估預測期內憂鬱症領域複合年成長率最高

由於神經調節療法的接受度不斷提高以及抗治療性憂鬱症（TRD）的盛行率不斷上升，憂鬱症領域預計將在預測期內實現最高成長率。深部腦部刺激（DBS）和迷走神經刺激（VNS）正成為傳統抗憂鬱症的有效治療方法。正在進行的臨床試驗以及用於情緒調節的封閉回路型系統的開發，增加了人們對植入式解決方案的興趣。此外，新冠疫情（COVID-19）疫情導致的心理健康危機日益惡化，凸顯了對新型療法的需求，從而刺激了對這一快速發展領域的投資和研究。

比最大的地區

預計北美地區將在預測期內佔據最大的市場佔有率，主要由美國推動，美國對全球市場的收益貢獻巨大。高昂的醫療支出、先進的醫療基礎設施以及憂鬱症、癲癇和帕金森氏症等神經系統疾病的盛行率不斷上升，都使該地區受益。北美的主導地位也歸因於頂級公司的存在、優惠的報銷政策以及持續的研發計劃。此外，推動該地區市場擴張並使其成為全球主要參與者的因素是人們對腦植入及其在治療長期神經系統疾病方面的有效性的認知不斷提高。

複合年成長率最高的地區：

預計亞太地區將在預測期內實現最高的複合年成長率。這得益於神經系統疾病發病率的上升、投資的增加以及醫療基礎設施的快速改善。由於人口老化、人們對大腦健康的認知不斷提高以及醫療保健服務的便利性，中國、印度和日本等國家對尖端醫療技術的需求日益成長。旨在改善醫療體系的政府計畫和投資也在推動市場擴張。此外，由於該地區患者人數眾多且可支配收入不斷成長，該地區未來成長前景廣闊，這也影響了腦植入技術的普及。

免費客製化服務：

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究資訊來源
    • 初級研究資訊來源
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

第5章 全球腦植入市場（按產品）

  • 深層腦部刺激器
  • 迷走神經刺激
  • 反應性神經刺激

6. 全球腦植入市場（依應用）

  • 慢性疼痛
  • 癲癇
  • 帕金森氏症
  • 憂鬱症
  • 阿茲海默症
  • 自發性震顫
  • 其他用途

7. 全球腦植入市場（按最終用戶）

  • 醫院
  • 神經科診所
  • 其他最終用戶

8. 全球腦植入市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第9章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司概況

  • Boston Scientific Corporation
  • Medtronic plc
  • Synchron Inc.
  • Abbott Laboratories
  • NeuroPace, Inc.
  • LivaNova Plc
  • Precision Neuroscience Inc
  • NDI Medical LLC
  • Renishaw PLC
  • Aleva Neurotherapeutics SA
  • Beijing PINS Medical Co., Ltd
  • Functional Neuromodulation, Ltd.
  • SceneRay Co., Ltd
  • Cyberonics, Inc.
  • NeuroSigma Inc
Product Code: SMRC29533

According to Stratistics MRC, the Global Brain Implants Market is accounted for $7.40 billion in 2025 and is expected to reach $16.26 billion by 2032 growing at a CAGR of 11.9% during the forecast period. Advanced medical devices known as brain implants, when inserted directly into the brain, facilitate communication with neural tissue. Numerous therapeutic, diagnostic, and enhancement applications exist for these implants. They work by capturing or triggering brain activity, frequently by sending and receiving electrical signals via electrodes. The safety, functionality, and possible uses of brain implants have been greatly enhanced by recent developments in materials science, wireless technology, and machine learning.

According to the American Association of Neurological Surgeons (AANS), approximately 250,000 individuals in the U.S. are affected by dystonia, a neurological movement disorder characterized by involuntary muscle contractions.

Market Dynamics:

Driver:

Increasing neurological disorder prevalence

The prevalence of neurological disorders is rising at a startling rate worldwide. Millions of people worldwide suffer from conditions like epilepsy, Parkinson's disease, Alzheimer's, chronic pain, and depression that don't go away. For example, according to estimates from the World Health Organization (WHO), more than 50 million people worldwide have epilepsy. By controlling aberrant neural activity and enhancing patients' quality of life, brain implants provide an efficient intervention. Moreover, the need for implantable neurostimulation devices is growing since traditional treatments frequently fail, particularly in cases where the patient is drug-resistant.

Restraint:

Expensive procedures and equipment

Deep brain stimulation (DBS) systems and other brain implants are costly; without accounting for surgical and postoperative costs, they can cost anywhere from $35,000 to $50,000 per patient. An important obstacle to access is the high initial and ongoing costs, especially in low- and middle-income nations. Insurance coverage may be restricted, even in developed areas, which deters patients from choosing such treatments. Additionally, the cost burden also affects healthcare systems, particularly when long-term monitoring, device upkeep, and possible issues necessitating adjustments are taken into account.

Opportunity:

Growth of BCIs (brain-computer interfaces)

Brain-computer interfaces (BCIs) are integrating brain implants with external computing systems, opening up revolutionary possibilities in healthcare and other fields. Through the use of brain-computer interfaces (BCIs), people who have lost limbs or are paralyzed can use neural signals to operate computers, wheelchairs, and prosthetic limbs. Initiatives like Synchron's endovascular BCIs and Elon Musk's Neuralink are garnering interest and funding for use in both therapeutic and non-medical fields. Furthermore, the market for brain implants may be greatly expanded outside of traditional medical settings as these technologies develop and find commercial use in communication, gaming, smart devices, and augmented cognition.

Threat:

Ethical backlash and public skepticism

The public is still skeptical of brain implants despite their technological potential because of ethical and philosophical issues. Advocacy groups and patients may find it difficult to accept someone who has mind control, loses autonomy, or changes their personality. In societies where the sanctity of the human brain is highly valued for religious or cultural reasons, invasive procedures are frequently resisted. Moreover, as brain implants start to conflate enhancement and treatment, there is growing discussion about ethical boundaries and possible abuse, which may result in restrictions or prohibitions in some markets.

Covid-19 Impact:

The COVID-19 pandemic affected the market for brain implants in a variety of ways. Initial market disruptions included a temporary drop in implant procedures and clinical trials as a result of supply chain disruptions, hospital capacity reductions, and the postponement of elective neurosurgeries. However, as healthcare systems looked into cutting-edge solutions for remote patient monitoring and chronic disease management, the pandemic also accelerated investments in neuro-technology and digital health. Additionally, long-term market growth is also anticipated due to the increased prevalence of neurological complications linked to prolonged COVID, such as brain fog, stroke, and cognitive dysfunction.

The deep brain stimulator (DBS) segment is expected to be the largest during the forecast period

The deep brain stimulator (DBS) segment is expected to account for the largest market share during the forecast period. DBS is the most widely used neuromodulation therapy, driven by its clinical success and widespread use in treating neurological disorders like Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder. It involves the implantation of electrodes in specific brain regions to deliver controlled electrical impulses, effectively modulating abnormal neural activity. Furthermore, it is FDA-approved, well-established, and supported by a wealth of clinical data, and its adoption is further enhanced by ongoing innovation in device miniaturization, battery life, and MRI compatibility.

The depression segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the depression segment is predicted to witness the highest growth rate, driven by the growing acceptance of neuromodulation therapies and the rising incidence of treatment-resistant depression (TRD). Deep brain stimulation (DBS) and vagus nerve stimulation (VNS) are becoming viable substitutes for traditional antidepressants, which frequently fail to relieve a considerable percentage of patients. Interest in implantable solutions is being fueled by ongoing clinical trials and developments in closed-loop systems designed for mood regulation. Additionally, the COVID-19 pandemic's worsening of the mental health crisis has highlighted the need for novel treatments, spurring investment and research in this rapidly expanding field.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, mostly driven by the United States, which contributes significantly to global market revenue. High healthcare spending, a sophisticated healthcare infrastructure, and an increasing incidence of neurological conditions like depression, epilepsy, and Parkinson's disease all benefit the area. The dominance of North America is also attributed to the existence of top businesses, advantageous reimbursement practices, and ongoing R&D initiatives. Furthermore, driving market expansion in this area and establishing it as a major player globally is growing awareness of brain implants and their effectiveness in treating long-term neurological disorders.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by the rising incidence of neurological disorders, growing investments, and quick improvements in healthcare infrastructure. The need for cutting-edge medical technologies is rising in nations like China, India, and Japan as a result of aging populations, growing awareness of brain health, and easier access to healthcare. Government programs and investments meant to improve healthcare systems also encourage market expansion. Moreover, the region is a very promising market for future growth because of its large patient population and growing disposable incomes, which are also influencing the adoption of brain implant technologies.

Key players in the market

Some of the key players in Brain Implants Market include Boston Scientific Corporation, Medtronic plc, Synchron Inc., Abbott Laboratories, NeuroPace, Inc., LivaNova Plc, Precision Neuroscience Inc, NDI Medical LLC, Renishaw PLC, Aleva Neurotherapeutics SA, Beijing PINS Medical Co., Ltd, Functional Neuromodulation, Ltd., SceneRay Co., Ltd, Cyberonics, Inc. and NeuroSigma Inc.

Key Developments:

In April 2025, Medtronic plc announced a strategic agreement to distribute the advanced Dragonfly(TM)* pancreaticobiliary system from Dragonfly Endoscopy, Inc. in the United States. This innovative platform introduces significant enhancements in pancreaticobiliary endoscopy - a field where procedural standards have remained largely unchanged for decades. Financial terms of the agreement were not disclosed.

In March 2025, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS(TM) Intravascular Ultrasound System. An investigational technology, the TIVUS system is designed to denervate nerves surrounding blood vessels to treat a variety of hypertensive disorders, including renal artery denervation (RDN) for hypertension.

In December 2024, Abbott Laboratories and DexCom said that they have reached an agreement to settle all patent disputes between them related to continuous glucose monitoring devices. The agreement will dismiss all pending cases in courts and patent offices worldwide, along with a provision preventing legal action between the companies for patent and appearance disputes for the next 10 years.

Products Covered:

  • Deep Brain Stimulator
  • Vagus Nerve Stimulation
  • Responsive Neurostimulation

Applications Covered:

  • Chronic Pain
  • Epilepsy
  • Parkinson's Disease
  • Depression
  • Alzheimer's Disease
  • Essential Tremor
  • Other Applications

End Users Covered:

  • Hospitals
  • Neurology Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Brain Implants Market, By Product

  • 5.1 Introduction
  • 5.2 Deep Brain Stimulator
  • 5.3 Vagus Nerve Stimulation
  • 5.4 Responsive Neurostimulation

6 Global Brain Implants Market, By Application

  • 6.1 Introduction
  • 6.2 Chronic Pain
  • 6.3 Epilepsy
  • 6.4 Parkinson's Disease
  • 6.5 Depression
  • 6.6 Alzheimer's Disease
  • 6.7 Essential Tremor
  • 6.8 Other Applications

7 Global Brain Implants Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Neurology Clinics
  • 7.4 Other End Users

8 Global Brain Implants Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Boston Scientific Corporation
  • 10.2 Medtronic plc
  • 10.3 Synchron Inc.
  • 10.4 Abbott Laboratories
  • 10.5 NeuroPace, Inc.
  • 10.6 LivaNova Plc
  • 10.7 Precision Neuroscience Inc
  • 10.8 NDI Medical LLC
  • 10.9 Renishaw PLC
  • 10.10 Aleva Neurotherapeutics SA
  • 10.11 Beijing PINS Medical Co., Ltd
  • 10.12 Functional Neuromodulation, Ltd.
  • 10.13 SceneRay Co., Ltd
  • 10.14 Cyberonics, Inc.
  • 10.15 NeuroSigma Inc

List of Tables

  • Table 1 Global Brain Implants Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Brain Implants Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Brain Implants Market Outlook, By Deep Brain Stimulator (2024-2032) ($MN)
  • Table 4 Global Brain Implants Market Outlook, By Vagus Nerve Stimulation (2024-2032) ($MN)
  • Table 5 Global Brain Implants Market Outlook, By Responsive Neurostimulation (2024-2032) ($MN)
  • Table 6 Global Brain Implants Market Outlook, By Application (2024-2032) ($MN)
  • Table 7 Global Brain Implants Market Outlook, By Chronic Pain (2024-2032) ($MN)
  • Table 8 Global Brain Implants Market Outlook, By Epilepsy (2024-2032) ($MN)
  • Table 9 Global Brain Implants Market Outlook, By Parkinson's Disease (2024-2032) ($MN)
  • Table 10 Global Brain Implants Market Outlook, By Depression (2024-2032) ($MN)
  • Table 11 Global Brain Implants Market Outlook, By Alzheimer's Disease (2024-2032) ($MN)
  • Table 12 Global Brain Implants Market Outlook, By Essential Tremor (2024-2032) ($MN)
  • Table 13 Global Brain Implants Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 14 Global Brain Implants Market Outlook, By End User (2024-2032) ($MN)
  • Table 15 Global Brain Implants Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 16 Global Brain Implants Market Outlook, By Neurology Clinics (2024-2032) ($MN)
  • Table 17 Global Brain Implants Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 18 North America Brain Implants Market Outlook, By Country (2024-2032) ($MN)
  • Table 19 North America Brain Implants Market Outlook, By Product (2024-2032) ($MN)
  • Table 20 North America Brain Implants Market Outlook, By Deep Brain Stimulator (2024-2032) ($MN)
  • Table 21 North America Brain Implants Market Outlook, By Vagus Nerve Stimulation (2024-2032) ($MN)
  • Table 22 North America Brain Implants Market Outlook, By Responsive Neurostimulation (2024-2032) ($MN)
  • Table 23 North America Brain Implants Market Outlook, By Application (2024-2032) ($MN)
  • Table 24 North America Brain Implants Market Outlook, By Chronic Pain (2024-2032) ($MN)
  • Table 25 North America Brain Implants Market Outlook, By Epilepsy (2024-2032) ($MN)
  • Table 26 North America Brain Implants Market Outlook, By Parkinson's Disease (2024-2032) ($MN)
  • Table 27 North America Brain Implants Market Outlook, By Depression (2024-2032) ($MN)
  • Table 28 North America Brain Implants Market Outlook, By Alzheimer's Disease (2024-2032) ($MN)
  • Table 29 North America Brain Implants Market Outlook, By Essential Tremor (2024-2032) ($MN)
  • Table 30 North America Brain Implants Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 31 North America Brain Implants Market Outlook, By End User (2024-2032) ($MN)
  • Table 32 North America Brain Implants Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 33 North America Brain Implants Market Outlook, By Neurology Clinics (2024-2032) ($MN)
  • Table 34 North America Brain Implants Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 35 Europe Brain Implants Market Outlook, By Country (2024-2032) ($MN)
  • Table 36 Europe Brain Implants Market Outlook, By Product (2024-2032) ($MN)
  • Table 37 Europe Brain Implants Market Outlook, By Deep Brain Stimulator (2024-2032) ($MN)
  • Table 38 Europe Brain Implants Market Outlook, By Vagus Nerve Stimulation (2024-2032) ($MN)
  • Table 39 Europe Brain Implants Market Outlook, By Responsive Neurostimulation (2024-2032) ($MN)
  • Table 40 Europe Brain Implants Market Outlook, By Application (2024-2032) ($MN)
  • Table 41 Europe Brain Implants Market Outlook, By Chronic Pain (2024-2032) ($MN)
  • Table 42 Europe Brain Implants Market Outlook, By Epilepsy (2024-2032) ($MN)
  • Table 43 Europe Brain Implants Market Outlook, By Parkinson's Disease (2024-2032) ($MN)
  • Table 44 Europe Brain Implants Market Outlook, By Depression (2024-2032) ($MN)
  • Table 45 Europe Brain Implants Market Outlook, By Alzheimer's Disease (2024-2032) ($MN)
  • Table 46 Europe Brain Implants Market Outlook, By Essential Tremor (2024-2032) ($MN)
  • Table 47 Europe Brain Implants Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 48 Europe Brain Implants Market Outlook, By End User (2024-2032) ($MN)
  • Table 49 Europe Brain Implants Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 50 Europe Brain Implants Market Outlook, By Neurology Clinics (2024-2032) ($MN)
  • Table 51 Europe Brain Implants Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 52 Asia Pacific Brain Implants Market Outlook, By Country (2024-2032) ($MN)
  • Table 53 Asia Pacific Brain Implants Market Outlook, By Product (2024-2032) ($MN)
  • Table 54 Asia Pacific Brain Implants Market Outlook, By Deep Brain Stimulator (2024-2032) ($MN)
  • Table 55 Asia Pacific Brain Implants Market Outlook, By Vagus Nerve Stimulation (2024-2032) ($MN)
  • Table 56 Asia Pacific Brain Implants Market Outlook, By Responsive Neurostimulation (2024-2032) ($MN)
  • Table 57 Asia Pacific Brain Implants Market Outlook, By Application (2024-2032) ($MN)
  • Table 58 Asia Pacific Brain Implants Market Outlook, By Chronic Pain (2024-2032) ($MN)
  • Table 59 Asia Pacific Brain Implants Market Outlook, By Epilepsy (2024-2032) ($MN)
  • Table 60 Asia Pacific Brain Implants Market Outlook, By Parkinson's Disease (2024-2032) ($MN)
  • Table 61 Asia Pacific Brain Implants Market Outlook, By Depression (2024-2032) ($MN)
  • Table 62 Asia Pacific Brain Implants Market Outlook, By Alzheimer's Disease (2024-2032) ($MN)
  • Table 63 Asia Pacific Brain Implants Market Outlook, By Essential Tremor (2024-2032) ($MN)
  • Table 64 Asia Pacific Brain Implants Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 65 Asia Pacific Brain Implants Market Outlook, By End User (2024-2032) ($MN)
  • Table 66 Asia Pacific Brain Implants Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 67 Asia Pacific Brain Implants Market Outlook, By Neurology Clinics (2024-2032) ($MN)
  • Table 68 Asia Pacific Brain Implants Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 69 South America Brain Implants Market Outlook, By Country (2024-2032) ($MN)
  • Table 70 South America Brain Implants Market Outlook, By Product (2024-2032) ($MN)
  • Table 71 South America Brain Implants Market Outlook, By Deep Brain Stimulator (2024-2032) ($MN)
  • Table 72 South America Brain Implants Market Outlook, By Vagus Nerve Stimulation (2024-2032) ($MN)
  • Table 73 South America Brain Implants Market Outlook, By Responsive Neurostimulation (2024-2032) ($MN)
  • Table 74 South America Brain Implants Market Outlook, By Application (2024-2032) ($MN)
  • Table 75 South America Brain Implants Market Outlook, By Chronic Pain (2024-2032) ($MN)
  • Table 76 South America Brain Implants Market Outlook, By Epilepsy (2024-2032) ($MN)
  • Table 77 South America Brain Implants Market Outlook, By Parkinson's Disease (2024-2032) ($MN)
  • Table 78 South America Brain Implants Market Outlook, By Depression (2024-2032) ($MN)
  • Table 79 South America Brain Implants Market Outlook, By Alzheimer's Disease (2024-2032) ($MN)
  • Table 80 South America Brain Implants Market Outlook, By Essential Tremor (2024-2032) ($MN)
  • Table 81 South America Brain Implants Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 82 South America Brain Implants Market Outlook, By End User (2024-2032) ($MN)
  • Table 83 South America Brain Implants Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 84 South America Brain Implants Market Outlook, By Neurology Clinics (2024-2032) ($MN)
  • Table 85 South America Brain Implants Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 86 Middle East & Africa Brain Implants Market Outlook, By Country (2024-2032) ($MN)
  • Table 87 Middle East & Africa Brain Implants Market Outlook, By Product (2024-2032) ($MN)
  • Table 88 Middle East & Africa Brain Implants Market Outlook, By Deep Brain Stimulator (2024-2032) ($MN)
  • Table 89 Middle East & Africa Brain Implants Market Outlook, By Vagus Nerve Stimulation (2024-2032) ($MN)
  • Table 90 Middle East & Africa Brain Implants Market Outlook, By Responsive Neurostimulation (2024-2032) ($MN)
  • Table 91 Middle East & Africa Brain Implants Market Outlook, By Application (2024-2032) ($MN)
  • Table 92 Middle East & Africa Brain Implants Market Outlook, By Chronic Pain (2024-2032) ($MN)
  • Table 93 Middle East & Africa Brain Implants Market Outlook, By Epilepsy (2024-2032) ($MN)
  • Table 94 Middle East & Africa Brain Implants Market Outlook, By Parkinson's Disease (2024-2032) ($MN)
  • Table 95 Middle East & Africa Brain Implants Market Outlook, By Depression (2024-2032) ($MN)
  • Table 96 Middle East & Africa Brain Implants Market Outlook, By Alzheimer's Disease (2024-2032) ($MN)
  • Table 97 Middle East & Africa Brain Implants Market Outlook, By Essential Tremor (2024-2032) ($MN)
  • Table 98 Middle East & Africa Brain Implants Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 99 Middle East & Africa Brain Implants Market Outlook, By End User (2024-2032) ($MN)
  • Table 100 Middle East & Africa Brain Implants Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 101 Middle East & Africa Brain Implants Market Outlook, By Neurology Clinics (2024-2032) ($MN)
  • Table 102 Middle East & Africa Brain Implants Market Outlook, By Other End Users (2024-2032) ($MN)